Type B3 thymoma
Prepared with OnCo (onco.cc/prep/thymoma-type-b3/). Orientation, not medical advice; your team knows your case.
My details
What I know, what is unclear, changes to discuss
Saved in this browserMy questions
8 on the sheet- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example WHO histotype on ITMIG criteria; absence of CD5 and CD117, Masaoka-Koga or TNM stage and resection status, Acetylcholine receptor antibodies, Ki-67 and mitoses), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
- 5.For my situation (all stages), which of the standard options do you recommend and why?
- 6.Am I a candidate for Cisplatin, Doxorubicin, Cyclophosphamide, and what side effects should I expect?
- 7.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 8.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
Tests and results to bring
Biomarker results to ask for: WHO histotype on ITMIG criteria; absence of CD5 and CD117 (thymic carcinoma markers), Masaoka-Koga or TNM stage and resection status, Acetylcholine receptor antibodies (myasthenia gravis), Ki-67 and mitoses.
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- All stages: Resection with postoperative radiotherapy for stage II to III or incomplete resection; induction platinum-based chemotherapy for unresectable tumours; recurrence as on the parent page. (Thymoma (WHO types A, AB, B1, B2 and B3), Thymic carcinoma, Cisplatin, Doxorubicin, Cyclophosphamide)
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.